Sign In
25 Jun 2012 09:00
ο»Ώ
PuriCore plc
Β
Director's Dealing
Β
PuriCore (LSE: PURI), the water-based clean technology company, today announces, in accordance with the Disclosure and Transparency Rules, that on 22 June 2012 the following Director purchased ordinary shares of 10p each in the Company, as set out below.
Name Β | Number of shares purchased | Purchase price of shares | Shareholding following the purchase | % of issued share capital |
James Walsh | 10,000 | 50p | 10,000 | 0.04% |
Senior Independent Non-Executive Director | ||||
Β
Enquiries:
FTI Consulting
Susan Stuart
Victoria Foster Mitchell
+44 (0) 20 7831 3113
Β
About PuriCore
PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. PuriCore's patented, proprietary technology offers a safe and non-hazardous approach to disinfection and sanitisation. The Company's products are used in a broad range of markets that depend upon controlling contamination, including supermarketretail, medical device disinfection, and wound care. PuriCore's Solutions are proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK.
Β
To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.
Β
Follow the stocks
